Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Donald Gordon Jewell Insider Profile
4 Followers
Donald Gordon Jewell, Former Director at Arbutus Biopharma, holds 484.67K shares in Arbutus Biopharma (Ticker: ABUS).
Donald Gordon Jewell has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Donald Gordon Jewell's holdings
Insider Roles
Former Director
Roles that Donald Gordon Jewell holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Donald Gordon Jewell
Donald Gordon Jewell's Trading History
List of latest transactions for each holding click on a transaction to see Donald Gordon Jewell's performance on stock
You May Also Like
Donald Gordon Jewell insider profile FAQ
What is the percentage of profitable transactions made by Donald Gordon Jewell?
The percentage of profitable transactions made by Donald Gordon Jewell is ―.
What is the average return per transaction made by Donald Gordon Jewell?
The average return per transaction made by Donald Gordon Jewell is ―.
What stocks does Donald Gordon Jewell hold?
Donald Gordon Jewell holds: ABUS stocks.
What was Donald Gordon Jewell’s latest transaction?
Donald Gordon Jewell latest transaction was an Uninformative Buy of ―.
What was Donald Gordon Jewell's most profitable transaction?
Donald Gordon Jewell’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Donald Gordon Jewell's role in Arbutus Biopharma?
Donald Gordon Jewell's role in Arbutus Biopharma is Former Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.